Cargando…
Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion
INTRODUCTION: A combination of platelet and lymphocyte to monocyte ratio (LMR) (abbreviated as COP-LMR) has been recently evaluated as systemic inflammatory marker for prognostication in lung cancer. While previous study on COP-LMR has evaluated its prognostic value in NSCLC patients who underwent c...
Autores principales: | Lim, Jeong Uk, Yeo, Chang Dong, Kang, Hye Seon, Park, Chan Kwon, Kim, Ju Sang, Kim, Jin Woo, Kim, Seung Joon, Lee, Sang Haak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044534/ https://www.ncbi.nlm.nih.gov/pubmed/30005083 http://dx.doi.org/10.1371/journal.pone.0200341 |
Ejemplares similares
-
Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion
por: Lim, Jeong Uk, et al.
Publicado: (2019) -
Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
por: Lim, Jeong Uk, et al.
Publicado: (2021) -
Pleural Fluid Pentraxin-3 for the Differential Diagnosis of Pleural Effusions
por: Yeo, Chang Dong, et al.
Publicado: (2013) -
Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)
por: Verma, Akash, et al.
Publicado: (2016) -
Association of the Preoperative Neutrophil-to-ymphocyte Count Ratio and Platelet-to-Lymphocyte Count Ratio with Clinicopathological Characteristics in Patients with Papillary Thyroid Cancer
por: Kim, Sang Mi, et al.
Publicado: (2015)